Control of Cell Volume and Membrane Potential

合集下载

Physiology 生理学重点

Physiology 生理学重点

Define the following terms and list the example1Internal environment: All cells live in the same environment ——the extracelluar fluid. In the extracellular fluid are the ions and nutrients needed by the cell to maintain cell life. For this reason, the environment fluid is also called the internal environment.2Homestasis: can maintain the internal environment stable which means the physical and chemical properties of extracelluar fluid only change in a limited range called normal physiological range.3 Negative feedback: A change in a condition leads to responses from the effectors which counteracts that change.4 Positive feedback:A change in a condition leads to responses from the effectors which amplifies.5 simple diffusion: lipid-soluble substances or small polar molecules diffusion directly through the interstices of the lipid bilayer.Example: oxygen, nitrogen, carbon dioxide, alcohols, H2O, urea6 Facilitated diffusion via ion channel: the channel facilitates diffusion of ions to the other side, three types: voltage-gated channel, chemical-gated channel and mechanically-gated channel. Ions(Na+,K+, Cl+, Ca+), H2O.Voltage-gated Channel电压门控Chemical-gated Channel化学门控Mechanically-gated Channel机械门控7 Facilitated diffusion via carrier: the carrier (transporter) facilitates diffusion of some lipid-in soluble moleclues to the other side. Glucose, amino acid8 Primary active transport: making directly use of energy derived from ATP to transport the ions across the cell membrane against their concentration gradients. Na+-K+ pump, calcium pump, proton pump9 Secondary active transport: The ion gradients established by primary active transport permits the transport of other substances against their concentration gradients. Na+-glucose pump, Na+-amino pump.10 Resting potential: A potential difference across the membrane of the cell negative relative to the outside of the cell11 polarization: A state in which the resting potential is positive on the outside and negative on the inside12 K+ equilibrium potential: “balance” means that the electrical force that results form the build-up of ionic charge, and which impedes outward diffusion, increases until it is equal in magnitude but opposite in direction to the tendency for outward diffusive movement of potassium. This balance point is an equilibrium potential as the net transmembrane flux of K+ is zero.13 action potential: Some of the cells (excitable cells) are capable to rapidly reverse their resting membrane potential from negative resting values to slightly positive values. This transient and rapid change in membrane potential is calledan action potential.14 Threshold potential:is the critical level to which the membrane potential must be depolarization in order to initiate an action potential. Threshold intensity/value: the minimal stimulus that produces excitation.15 saltatory conduction: the action potential are conducted from node to node16 excitability: the property of a cell that enables to react (generate AP) to stimulation, such as the ability of a nerve or muscle cell to react an electric stimulus.17 absolute refractory period: the period during which a second action potential cannot be elicited, even with a strong stimulus.18 end plate potential: the depolarizations of end plate membrane caused by Ach binding to N2-Ach receptors in the neuromuscular junction. It is a local potential.Ach门控通道阻断剂---α银环蛇毒Na+电压门控通道阻断剂---河豚毒TTX19 cross-bridge cycling: the muscle contractile process in which the cross-bridge binds to actin, twists and resets.20 excutation-contraction coupling: is the muscle physiological process of converting an electrical stimulus(action potential) to a mechanical response(muscle contraction).21 isometric contraction: tension increases but the length of the muscle does not change when a mucle contracts.22 isotonic contraction: tension remains constant but the muscle shortens whena mucle contracts.23 afterload: afterload is the load that is given to the muscle after the beginning of the contraction.24 preload: preload is the load that is given to the muscle before the beginning of the contraction. Preload=initial length25 hematocrit:the volume of red blood cell(erythrocytes) as a percentage of centrifuged whole blood.26 erythrocyte sedimentation rate:the distance that red blood cell settle in a tube of blood in one hour27 hemostasis: small damaged blood vessel stop bleeding after a few minute.28 blood coagulation: is the process that blood change from the sol to illiquid gel state.29 blood group: a classification of blood based on the presence or absence of inherited antigenic substances on the surface of red blood cells30 extrinsic pathway: the coagulation pathway initiated by FII exposed to blood which comes from outside the blood.31 intrinsic pathway: gradually clot the blood completely depending on the coagulation factors in the blood.32 stroke volume:volume of blood pumped out of each ventricle per beat. SV=EDV-ESV. At rest: SV:~70ml33 cardiac output:the total volume of blood pumped by each ventricle perminute. At rest: 5L/min(4.5-6.0L/min)34 ejection fraction (EF):Stroke volume as a percentage of end-diastolic ventricles. EF = SV/EDV╳100% . 60%35 cardiac index:cardiac output per square meter of body surface area.3.0~3.5L/(min·m2)36 cardiac reserve:the maximum percentage that the cardiac output can increase above the normal level.37 Frank-starling mechanism: The intrinsic ability of the heart to adapt to increasing volumes of inflowing blood through increasing ventricular end-diastole volume.938 heterometric regulation: the regulation of stroke volume as a result of changes in cardiac muscle fiber length is called heterometric regulation.39 homometric regulation::regulate the force of contraction without a change in muscle length40 cardiac cycle: The cardiac events that occur from beginning of one heart beat to the beginning of the next are called the cardiac cycle.Systole, diastole.41 end-systolic volume:As the ventricles empty during systole, the volume decreases about 70ml.The remaining volume in each ventricle,about 50ml,is called the end-systolic volume.42 end-diastolic volume: During diastole, filling of the ventricles increases the volume of each ventricle to about 130ml.This volume is called the End-diastolicvolume.心动周期中的几个“最”心室容积最低:减慢射血期末,等容舒张期,心室容积最大:心房收缩期末,等容收缩期室内压最高:快速射血期末43 premature systole: a contraction of the heart prior to the time that normal contraction would have been expected44 compensatory pause:the pause between the extra beat and the next normal beat is slightly longer than the usual beat interval, which is called compensatory pause.Premature systole is generally followed by a so-called conmpensatory pause, because the heart is still in the absolute refractory period of the extrasystole when the excitatory impulse from the SA node arrives.45 effective refractory period:the duration from the beining of phase 0 to -60mv of repolarization fails to produce action potential to any stimulus, no matter how strong. This duration is called ERP. In ERP, the excitability is almost zero.46 atrioventricular delay: The atrial muscle are separated from those of ventricles by a fibrous tissue ring. The AV node is normally the only conducting pathway between the atrial and ventricles. Because conduction in the AV node is slow, a delay of about 0.1s occours before excitation spread to the ventricles.47 Electrocardiogram (ECG) 心电图The electrocardiograph is a device to record the electrical signals produced bythe heart by placing electrodes on the surface of the skin. The recording obtained is called the electrocardiogram (ECG).48 systolic pressure:the maximum arterial pressure reached during peak ventricular ejection.49 diastolic pressure:the minimum arterial pressure just before ventricular ejection begins.50 pulse pressure: the difference between SP(systolic pressure) and DP(diastolic pressure)51 mean arterial pressure: the average pressure in the cardiac cycle(=DP+1/3PP)52 central venous pressure(CVP)pressure of blood in the thoracic vena cava and the right atrium.正常值:4-12cmH2OCVP >16cmH2O⚫(1) heart failure⚫(2) massive transfusion of blood53 venous return:refers to the flow of blood from the periphery back to the right atrium54 mcrocirculation:capillary blood circulation between the arteriole and venule55 respiration:The gas exchange process between organization and environment is named respiration.56 surface tension:Tension of a liquid's surface. Due to the forces of attraction between moleculesAnswer the questions1 Regulation of body function:Nervous regulationHumoral regulationAutoregulation2 Describe the physiological role of sodium pump:1 maintaining the Na+ and K+ gradients across the cell membrane, which is the basi to form bioelectricity.2 maintain the high concentration of K+ inside the cell, which is needed by the cell metabolism.3 controlling cell volume and osmotic pressure4 providing energy for secondary active transport5 partly responsible for establishing a negative electrical potential inside the cell.3 Factors affecting resting potential1 K+ concentration gradient.K+ concentration outside the membrane↑→RP↓2 membrane permeability to K+ and Na+More permeable to K+ →RP↑More permeable to Na+ →the RP↓3 the activity of Na+—K+ pumpHypopotassemia血钾过低→RP上升hyperpotassemia 过高→RP下降4 All-or-nothing principle1 stimulus must exceed threshold stimulus to trigger AP2 the amplitude of an AP is independent of the intensity of stimulus that produced it.3 either they occur fully or they do not occur at all5 Describe the ionic mechanism of AP1 change in electrochemical driving force2 change in membrane permeability6 Compare the properties of action potential with the local potential7 second messenger: cAMP, DG(DAG), IP3 cGMP Ca2+8 properties of action potential (AP)1AP ia all-or-none2AP propagates without decrement3Discharge in form of impulse: unfused(because of refractory period)9 describe neuromuscular transmissionDepolarization of prejunctional membrane make the voltage-gated calciumchannel open. Then the calcium enter into motor nerve ending. Calcium can promote the exocytosis of synaptic vesicle and Ach release. The Ach can activate N2-Ach receptor channel which can make the N2-Ach receptor cation channel open. Endplate membrane increase the permeability for sodium and potassium.(mianly sodium internal flow). Then endplate membrane deploarize which activates voltage-gated sodium channel. Finally skeletal muscle generate action potential.10 describe excitation coupling proceeds1. Spread of the Action Potential to the Interior of the Muscle Fiber by Way of T Tubules2. This depolarisation activates L-type calcium channels3. This activates RyR (calcium release channel)via foot processes4. As the RyRs open, calcium is released from the SR into the cytoplasm.5. The calcium binds to Troponin C by the actin filaments, to allow cross-bridge cycling, producing force and motion6. The SR calcium pump actively pumps calcium back into the SR. As calcium declines back to resting levels, the force declines and relaxation occur11 影响肌肉收缩的四大因素1 preload2 afterload3 contractility4 summation12 Crystalloid Osmotic Pressure 晶体渗透压◼ Pressure generated by all crystal substances, particularly NaCl.◼ maintaining fluid balance across cell membranes and the normal cell volume ◼ =interstitial fluidColloid Osmotic Pressure 胶体渗透压◼ Osmotic pressure generated by plasma proteins, particularly albumin.◼ maintaining fluid balance across capillaries and the normal blood volume ◼>interstitial fluid13 physiological properties of RBC1 plastic deformation2 suspension stability : erythrocyte sedimentation rate(the distance that red blood cell3 osmotic fragility settle in a tube of blood in one hour)Rouleaux formation →ESR↑14function of RBC biconcave discs1 Transport of O2 (98.5%) and CO22 BufferingKHCO3/H2CO3、KHb/HHb、KHbO2/HHbO2、K2HPO4/KH2PO415 production of RBC (erythropoiesis)◼ Site: bone marrow◼ Nutritional Requirements for Erythropoiesis: Iron and protein◼ Maturation of Red Blood Cells: Vitamin B12 (requirement of intrinsic factor)and folic acid ◼ Regulation of Erythropoiesis:EPODeficiencies of these factors lead to characteristic anemias(贫血)红细胞生成的调节因子:1 Intrinsic factor, 分泌:由壁细胞分泌的糖蛋白。

纳米管制作皮肤感应器 翻译 中英

纳米管制作皮肤感应器 翻译 中英

最后译文:纳米管弹性制作出皮肤般的感应器美国斯坦福大学的研究者发现了一种富有弹性且透明的导电性能非常好的薄膜,这种薄膜由极易感触的碳纳米管组成,可被作为电极材料用在轻微触压和拉伸方面的传感器上。

“这种装置也许有一天可以被用在被截肢者、受伤的士兵、烧伤方面接触和压迫的敏感性的恢复上,也可以被应用于机器人和触屏电脑方面”,这个小组如是说。

鲍哲南和他的同事们在他们的弹透薄膜的顶部和底部喷上一种碳纳米管的溶液形成平坦的硅板,覆盖之后,研究人员拉伸这个胶片,当胶片被放松后,纳米管很自然地形成波浪般的结构,这种结构作为电极可以精准的检测出作用在这个材料上的力量总数。

事实上,这种装配行为上很像一个电容器,用硅树脂层来存储电荷,像一个电池一样,当压力被作用到这个感应器上的时候,硅树脂层就收紧,并且不会改变它所储存的电荷总量。

这个电荷是被位于顶部和底部的硅树脂上的纳米碳管测量到的。

当这个复合膜被再次拉伸的时候,纳米管会自动理顺被拉伸的方向。

薄膜的导电性不会改变只要材料没有超出最初的拉伸量。

事实上,这种薄膜可以被拉伸到它原始长度的2.5倍,并且无论哪种方向不会使它受到损害的拉伸它都会重新回到原始的尺寸,甚至在多次被拉伸之后。

当被充分的拉伸后,它的导电性喂2200S/cm,能检测50KPA的压力,类似于一个“坚定的手指捏”的力度,研究者说。

“我们所制作的这个纳米管很可能是首次可被拉伸的,透明的,肤质般感应的,有或者没有碳的纳米管”小组成员之一Darren Lipomi.说。

这种薄膜也可在很多领域得到应用,包括移动设备的屏幕可以感应到一定范围的压力而不仅限于触摸;可拉伸和折叠的几乎不会毁坏的触屏感应器;太阳能电池的透明电极;可包裹而不会起皱的车辆或建筑物的曲面;机器人感应装置和人工智能系统。

其他应用程序“其他系统也可以从中受益—例如那种需要生物反馈的—举个例子,智能方向盘可以感应到,如果司机睡着了,”Lipomi补充说。

《环境功能材料及其表征技术》课件

《环境功能材料及其表征技术》课件

Aggregation occurs when there is a net attraction and an equilibrium separation between the components
Whitesides G. M., Boncheva M. PNAS 2002;99:4769-4774 Copyright ©2002, The National Academy of Sciences
Self-Assembly
• Self-assembly is a process in which components, either separate or linked, spontaneously form ordered aggregates. • Self-assembly can occur with components having sizes from the molecular to the macroscopic, provided that appropriate conditions are met.
STM image of dodecanethiol on gold(111) prepared by adsorption from a millimolar solution of dodecanethiol in ethanol
Assembly of DNA Monolayers
STM of Self-Assembled Monolayer
Importance of Self-Assembly
First: it is centrally important in life. The cell contains an astonishing range of complex structures such as lipid membranes, folded proteins, structured nucleic acids, protein aggregates, molecular machines, and many others that form by self-assembly. Second: self-assembly provides routes to a range of materials with regular structures: molecular crystals, liquid crystals, and semicrystalline and phase-separated polymers are examples. Third: self-assembly also occurs widely in systems of components larger than molecules, and there is great potential for its use in materials and condensed matter science. Fourth: self-assembly seems to offer one of the most general strategies now available for generating nanostructures.

DiscoverX GPCR Cell Lines和Membrane Preparations产品说

DiscoverX GPCR Cell Lines和Membrane Preparations产品说

GPCR Cell Lines and Membrane PreparationsTHE KEYS TOUNLOCK DISCOVERYPaving the Way for Meaningful Solutions in Your ResearchCOME EXPLORE ONE OF THE LARGEST GPCR CELL LINES PORTFOLIO.Life science researchers are always working toward the nextbreakthrough discovery. For scientists working on GPCRs, speed is everything. And when it comes to drug discovery, overcoming the challenge of decreasing assay development time and accelerating your research, is necessary for success.You don’t have to face this obstacle alone. We’re here, delivering a comprehensive collection of more than:n 400 stable cell lines for binding and functional testing n 150 frozen ready-to-use cells n 100 membrane preparations◆ INTRODUCTION ◆ STABLE CELL LINES ◆ FROZEN CELLS◆ MEMBRANE PREPARATIONS ◆ TAG-LITE TECHNOLOGY ◆ TOTAL GPCR SOLUTION ◆ CONTACT USWork Faster. Work Better. Decreasing assay development time while increasing the quality of your results is a lofty goal, but necessary for research labs like yours to keep up with the competition.So, we’ve made the nearly impossible totally probable with our validated, stable GPCR cell lines for calcium, binding, and functional testing – because when you eliminate the guess work, you can focus on the science.Choose from stable GPCR cell lines expressingthe most studied targets, including:n Adenosinesn Adrenoceptorsn Cannabinoidsn Chemokinesn DopaminesFor more information on stable cell lines, click here.④OUR STABL Y TRANSFECTED CELL LINE PORTFOLIO ValiScreen® cell line family consists of transfected GPCR cell lines AequoScreen® cell line family comprises double-transfected GPCR aequorin cell lines for convenient calcium signaling measurement PhotoScreen® cell line family features double-transfected GPCR Photina® cell lines for convenient calcium signaling measurementn Galaninsn Histamines n Opioidsn Muscarinics n Serotonins◆ INTRODUCTION◆ STABLE CELL LINES◆ FROZEN CELLS◆ MEMBRANE PREPARATIONS◆ TAG-LITE TECHNOLOGY◆ TOTAL GPCR SOLUTION◆ CONTACT USLEARN MOREReady Whenever You Are Take the stress out of functional testing with our frozen, validated, ready-to-use cells. These growth-arrested cells express a variety of GPCRs for binding and functional assays.By using frozen cells, the cell prep work is done for you, eliminating the lengthy process of cell culture from your functional testing.Our consistent, flexible, and convenient frozen cells enable you to quickly and cost effectively perform selectivity studies and cellular GPCR tests on multiple receptors at a time – for streamlined screening, lead optimization, and profiling.Choose from stable GPCR cell lines expressingthe most studied targets, including:n Adrenergicn Anaphylatoxinn Chemokinen Histaminen Melantocortinn MuscarinicFor more information on frozen cells, click here.④OUR STABL Y TRANSFECTEDCELL LINE PORTFOLIOcAMPZEN™ frozen cell family consistsof transfected GPCR cell linesAequoZen™ frozen cell familycomprises double-transfected GPCRaequorin cell lines for convenientcalcium signaling measurement◆ INTRODUCTION◆ STABLE CELL LINES◆ FROZEN CELLS◆ MEMBRANE PREPARATIONS◆ TAG-LITE TECHNOLOGY◆ TOTAL GPCR SOLUTION◆ CONTACT USLEARN MOREMembrane Preparations Made SimpleOur membrane target systems offer a selection of products to help you identify and characterize ligands that bind to your receptor of interest. These membranes are quality assured and prepared from cells that express recombinant or endogenous GPCRs. Each lot of frozen membranes has been QC tested to determine receptor density and affinity.Our membrane preparations are derived from stable cell lines expressing ion channel, transporter, tyrosine kinase, and several GPCRs. They’re also qualified for either ligand binding or GTPγS functional studies.Well characterized and representing a wide range of pharmacologically important targets, our GPCR membrane preparations can be used for competitive radioligand binding assays as well as studies involving our HTRF ® and DELFIA ® technologies. Choose from GPCR membrane preparations expressing the most studied targets, including:n Adenosine n Adrenergic n Cannabinoid n Dopamine n GABAFor more information on membrane preparations, click here. ④n Melanocortin n Muscarinic n Opioid n Serotonin◆ INTRODUCTION ◆ STABLE CELL LINES ◆ FROZEN CELLS◆ MEMBRANE PREPARATIONS ◆ TAG-LITE TECHNOLOGY ◆ TOTAL GPCR SOLUTION ◆ CONTACT USThe Preferred Ligand Binding TechnologyOur Tag-lite ® solution is quickly becoming the industry standard for studying receptor-ligand binding interactions.A non-radioactive, cell-based technology, it enables the investigation of natural ligands, small molecules, or antibodies binding to cell surface receptors. It’s especially advantageous for GPCR and RTK investigations, biotherapeutic antibody development, and the study of ligand kinetics.It offers straightforward add-and-read protocols that help you characterize the binding properties of compounds, regardless of their chemical structures or pharmacological properties.Benefits of Tag-lite cellular binding assays:n Nonradioactiven Homogeneous and filtration-freen Ready-to-use kits, frozen cells, and reagents available n Does not alter the receptor pharmacology n Peer reviewed and validatedn Thorough kinetic studies with true Kd values, Ki, association (Kon), and dissociation (Koff) rate constantsCryptate-labeled receptorCompeting compoundFluorophore-labeled ligandNo FRET signal◆ INTRODUCTION ◆ STABLE CELL LINES ◆ FROZEN CELLS◆ MEMBRANE PREPARATIONS ◆ TAG-LITE TECHNOLOGY ◆ TOTAL GPCR SOLUTION ◆ CONTACT USLEARN MOREThe GPCR Portfolio That Leaves Nothing OutOUR GPCR PRODUCT PORTFOLIOWith drug discovery focused on GPCR targets, the need for reliable, proven, and versatile assays, reagents, andinstrumentation has never been greater. Understanding complex signaling mechanisms with speed and accuracy can mean the difference between success and failure.We recognize the significant challenges scientists like you face every day to identify biologically and pharmacologicallyrelevant pathways. Our extensive experience in both cellular and biochemical platforms enables us to guide and support your work every step of the way, from quickly optimizing your research to customizing solutions for specific target research.We’ve developed the widest selection of proven GPCR target solutions –beyond the ligand GPCR event to the actual assessment of the cellular-activated signal transduction cascade – empowering you to identify, validate, screen, and profile your leads. It’s time to get more from your research.Reporter gene assays for fast, simple, cost-effective screeningNEN ™ Radioligands that offer both tritiated and iodinated ligandsHTRF ®cAMP assays for highly sensitivescreeningAlphaLISA ® SureFire ® Ultra ™ and HTRF ® detection assays for cellular-phosphorylation of ERKIP-One HTRF and AlphaLISA detection kits for specific for Gq-coupled activation◆ INTRODUCTION ◆ STABLE CELL LINES ◆ FROZEN CELLS◆ MEMBRANE PREPARATIONS ◆ TAG-LITE TECHNOLOGY ◆ TOTAL GPCR SOLUTION ◆ CONTACT USLEARN MOREFor more information visit /category/gpcr-researchPerkinElmer, Inc.940 Winter StreetWaltham, MA 02451 USAP: (800) 762-4000 or(+1) 203-925-4602For a complete listing of our global offices, visit /ContactUsCopyright ©2021, PerkinElmer, Inc. All rights reserved. PerkinElmer® is a registered trademark of PerkinElmer, Inc. All other trademarks are the property of their respective owners.270755 PKI。

久保田MBR设计

久保田MBR设计

Type 510
Width (mm) 490
Length (mm) 1000
Effective area (m2/cartridge) 0.8
Remarks
5
3 Selection of Membrane Unit
Type of membrane unit
Height (mm) Type
Membrane case + Diffuser case
Î depending on * Type of influent wastewater * Influent strength * Water temperature etc
Î Design flux rate is consulted by Kubota
Table 1-1 Size of membrane cartridge
Note : Excess sludge contains nitrogen, and this nitrogen is removed together with withdrawal of the excess sludge. Influent T-N conc. x Influent flowrate can be replaced to nitrogen remained after this withdrawal.
Upper membrane case
Intermediate case Lower membrane case
Tub
Diffuser
Single deck unit (ES, FS)
Double deck unit
(EK)
3
3. Component of membrane case

生物药剂学与药物动力学专业词汇

生物药剂学与药物动力学专业词汇

生物药剂学与药物动力学专业词汇※<A>Absolute bioavailability, F 绝对生物利用度Absorption 吸收Absorption pharmacokinetics 吸收动力学Absorption routes 吸收途径Absorption rate 吸收速率Absorption rate constant 吸收速率常数Absorptive epithelium 吸收上皮Accumulation 累积Accumulation factor 累积因子Accuracy 准确度Acetylation 乙酰化Acid glycoprotein 酸性糖蛋白Active transport 主动转运Atomic absorption spectrometry 原子吸收光谱法Additive 加和型Additive errors 加和型误差Adipose 脂肪Administration protocol 给药方案Administration route 给药途径Adverse reaction 不良反应Age differences 年龄差异Akaike’s information criterion, AIC AIC判据Albumin 白蛋白All-or-none response 全或无效应Amino acid conjugation 氨基酸结合Analog 类似物Analysis of variance, ANOVA ANOVA方差分析Anatomic Volume 解剖学体积Antagonism 拮抗作用Antiproliferation assays 抑制增殖法Apical membrane 顶端表面Apoprotein 载脂蛋白脱辅基蛋白Apparatus 仪器Apparent volume of distribution 表观分布容积Area under the curve, AUC 曲线下面积Aromatisation 芳构化Artery 动脉室Artifical biological membrane 人工生物膜Aryl 芳基Ascorbic acid 抗坏血酸维生素C Assistant in study design 辅助实验设计Average steady-state plasma drug concentration 平均稳态血浆药物浓度Azo reductase 含氮还原酶※<B>Backward elimination 逆向剔除Bacteria flora 菌丛Basal membrane 基底膜Base structural model 基础结构模型Basolateral membrane 侧底膜Bayesian estimation 贝易斯氏评估法Bayesian optimization 贝易斯优化法Bile 胆汁Billiary clearance 胆汁清除率Biliary excretion 胆汁排泄Binding 结合Binding site 结合部位Bioactivation 生物活化Bioavailability, BA 生物利用度Bioequivalence, BE 生物等效性Biological factors 生理因素Biological half life 生物半衰期Biological specimen 生物样品Biomembrane limit 膜限速型Biopharmaceutics 生物药剂学Bioequivalency criteria 生物等效性判断标准Biotransformation 生物转化Biowaiver 生物豁免Blood brain barrier, BBB BBB血脑屏障Blood clearance 血液清除率Blood flow rate-limited models 血流速度限速模型Blood flux in tissue 组织血流量Body fluid 体液Buccal absorption of drug 口腔用药的吸收Buccal mucosa 口腔粘膜颊粘膜Buccal spray formulation 口腔喷雾制剂※<C>Capacity limited 容量限制Carrier mediated transport 载体转运Catenary model 链状模型Caucasion 白种人Central compartment 中央室Characteristic 特点Chelate 螯合物Chinese Traditional medicine products 中药制剂Cholesterol esterase 胆固醇酯酶Chromatogram 色谱图Circulation 循环Classification 分类Clearance 清除率Clinical testing in first phase I期临床试验Clinical testing in second phase Ⅱ期临床试验Clinical testing in third phase Ⅲ期临床试验Clinical trial 临床试验Clinical trial simulation 临床实验计划仿真Clockwise hysteresis loop 顺时针滞后回线Collection 采集Combined administration 合并用药Combined errors 结合型误差Common liposomes, CL 普通脂质体Compartment models 隔室模型Compartments 隔室Competitive interaction 竞争性相互作用Complements 补体Complex 络合物Confidential interval 置信区间Conjugation with glucuronic acid 葡萄糖醛酸结合Controlled-release preparations 控释制剂Control stream 控制文件Conventional tablet 普通片Convergence 收敛Convolution 卷积Corresponding relationship 对应关系Corticosteroids 皮质甾体类Counter-clockwise hysteresis loop 逆时针滞后回线Countermeasure 对策Course in infusion period 滴注期间Covariance 协方差Covariates 相关因素Creatinine 肌酐Creatinine clearance 肌酐清除率Cytochrome P450, CYP450 细胞色素P450 Cytoplasm 细胞质Cytosis 胞饮作用Cytosol 胞浆胞液质※<D>Data File 数据文件Data Inspection 检视数据Deamination 脱氨基Deconvolution 反卷积Degree of fluctuation, DF DF波动度Delayed release preparations 迟释制剂Desaturation 降低饱和度Desmosome 桥粒Desulfuration 脱硫Detoxication 解毒Diagnosis 诊断Diffusion 扩散作用Dietary factors 食物因素Displacement 置换作用Disposition 处置Dissolution 溶解作用Distribution 分布Dosage adjustment 剂量调整Dosage form 剂型Dosage form design 剂型设计Dosage regimen 给药方案Dose 剂量dose-proportionality study 剂量均衡研究Dropping pills 滴丸Drug absorption via eyes 眼部用药物的吸收Drug binding 药物结合Drug concentration in plasma 血浆中药物浓度Drug Delivery System, DDS 药物给药系统Drug interaction 药物相互作用Drug-plasma protein binding ratio 药物—血浆蛋白结合率Drug-Protein Binding 药物蛋白结合Drug transport to foetus 胎内转运※<E>Efficient concentration range 有效浓度范围Efflux 外排Electrolyte 电解质Electro-spray ionization, ESI 电喷雾离子化Elimination 消除Elimination rate constant 消除速度常数Elongation 延长Emulsion 乳剂Endocytosis 入胞作用Endoplasmic reticulum 内质网Enterohepatic cycle 肠肝循环Enzyme 酶Enzyme induction 酶诱导Enzyme inhibition 酶抑制Enzyme-linked immunosorbent assays ELISA 酶联免疫法Enzymes or carrier-mediated system 酶或载体—传递系统Epithelium cell 上皮细胞Epoxide hydrolase 环化物水解酶Erosion 溶蚀Excretion 排泄Exocytosis 出胞作用Exons 外显子Experimental design 实验设计Experimental procedures 实验过程Exponential errors 指数型误差Exposure-response studies 疗效研究Extended least squares, ELS 扩展最小二乘法Extended-release preparations 缓控释制剂Extent of absorption 吸收程度External predictability 外延预见性Extraction ratio 抽取比Extract recovery rate 提取回收率Extrapolation 外推法Extravascular administration 血管外给药※<F>F test F检验Facilitated diffusion 促进扩散Factors of dosage forms 剂型因素Fasting 禁食Fibronectin 纤粘连蛋白First order rate 一级速度First Moment 一阶矩First order absorption 一级吸收First-order conditional estimation, FOCE 一级条件评估法First-order estimation, FO 一级评估法Fiest-order kinetics 一级动力学First pass effect 首过作用首过效应Fixed-effect parameters 固定效应参数Flavoprotein reductaseNADPH-细胞色素还原酶附属黄素蛋白还原酶Flow-through cell dissolution method 流室法Fluorescent detection method 荧光检测法Fraction of steady-state plasma drug concentration 达稳分数Free drug 游离药物Free drug concentration 游离药物浓度※<G>Gap junction 有隙结合Gas chromatography, GC 气相色谱法Gasrtointestinal tract, GI tract 胃肠道Gender differences 性别差异Generalized additive modeling, GAM 通用迭加模型化法Glimepiride 谷胱甘肽Global minimum 整体最小值Glomerular filtration 肾小球过滤Glomerular filtration rate, GFR 肾小球过滤率Glucuonide conjugation 葡萄糖醛酸结合Glutathione conjugation 谷胱甘肽结合Glycine conjugation 甘氨酸结合Glycocalyx 多糖—蛋白质复合体Goodness of Fit 拟合优度Graded response 梯度效应Graphic method 图解法Gut wall clearance肠壁清除率※<H>Half life 半衰期Health volunteers 健康志愿者Hemodialysis 血液透析Hepatic artery perfusion administration 肝动脉灌注给药Hepatic clearance, Clh 肝清除率Hierarchical Models 相同系列药物动力学模型High performance liquid chromatography, HPLC 高效液相色谱Higuchi equation Higuchi 方程Homologous 类似Human liver cytochrome P450 人类肝细胞色素P450 Hydrolysis 水解Hydroxylation 羟基化Hysteresis 滞后Hysteresis of plasma drug concentration 血药浓度滞后于药理效应Hysteresis of response 药理效应滞后于血药浓度※<I>Immunoradio metrec assays, IRMA 免疫放射定量法Incompatibility 配伍禁忌Independent 无关,独立Individual parameters 个体参数Individual variability 个体差异Individualization of drug dosage regimen 给药方案的个体化Inducer 诱导剂Induction 诱导Infusion 输注Inhibition 抑制Inhibitor 抑制剂Initial dose 速释部分Initial values 初始值Injection sites 注射部位Insulin 胰岛素Inter-compartmental clearance 隔室间清除率Inter-individual model 个体间模型Inter-individual random effects 个体间随机效应Inter-individual variability 个体间变异性Intermittence intravenous infusion 间歇静脉输液Internal predictability 内延预见性Inter-occasion random effects 实验间随机效应Intestinal bacterium flora 肠道菌丛Intestinal metabolism 肠道代谢Intra-individual model 个体内模型Intra-individual variability 个体内变异性Intramuscular administration 肌内给药Intramuscular injection 肌内注射Intra-peritoneal administration 腹腔给药Intravenous administration 静脉给药Intravenous infusion 静脉输液Intravenous injection 静脉注射Intrinsic clearance固有清除率内在清除率Inulin 菊粉In vitro experiments 体外试验In vitro–In vivo correlation, IVIVC 体外体内相关关系In vitro mean dissolution time, MDT vitro 体外平均溶出时间In vivo Mean dissolution time, MDT vivo 体内平均溶出时间Ion exchange 离子交换Isoform 异构体Isozyme 同工酶※<K>Kerckring 环状皱褶Kidney 肾※<L>Lag time 滞后时间Laplace transform 拉普拉斯变换Lateral intercellular fluid 侧细胞间隙液Lateral membrane 侧细胞膜Least detection amount 最小检测量Linearity 线性Linear models 线性模型Linear regression method 线性回归法Linear relationship 线性关系Lipoprotein 脂蛋白Liposomes 脂质体Liver flow 肝血流Local minimum 局部最小值Loading dose 负荷剂量Logarithmic models 对数模型Long circulation time liposomes 长循环脂质体Loo-Riegelman method Loo-Riegelman法Lowest detection concentration 最低检测浓度Lowest limit of quantitation 定量下限Lowest steady-state plasma drug concentration 最低稳态血药浓度Lung clearance 肺清除率Lymphatic circulation 淋巴循环Lymphatic system 淋巴系统※<M>Maintenance dose 维持剂量Mass balance study 质量平衡研究Masticatory mucosa 咀嚼粘膜Maximum likelihood 最大似然性Mean absolute prediction error, MAPE 平均绝对预测误差Mean absorption time, MAT 平均吸收时间Mean disintegration time, MDIT 平均崩解时间Mean dissolution time, MDT 平均溶出时间Mean residence time, MRT 平均驻留时间Mean sojourn time 平均逗留时间Mean squares 均方Mean transit time 平均转运时间Membrane-limited models 膜限速模型Membrane-mobile transport 膜动转运Membrane transport 膜转运Metabolism 代谢Metabolism enzymes 代谢酶Metabolism locations 代谢部位Metabolites 代谢物Metabolites clearance, Clm 代谢物清除率Method of residuals 残数法剩余法Methylation 甲基化Michaelis-Menten equation 米氏方程Michaelis-Menten constant 米氏常数Microbial assays 微生物检定法Microsomal P-450 mixed-function oxygenases 肝微粒体P-450混合功能氧化酶Microspheres 微球Microvilli 微绒毛Minimum drug concentration in plasma 血浆中最小药物浓度Mixed effects modeling 混合效应模型化Mixed-function oxidase, MFO 混合功能氧化酶Models 模型Modeling efficiency 模型效能Model validation 模型验证Modified release preparations 调释制剂Molecular mechanisms 分子机制Mono-exponential equation 单指数项公式Mono-oxygenase 单氧加合酶Mucous membrane injury 粘膜损伤Multi-compartment models 多室模型延迟分布模型Multi-exponential equation 多指数项公式Multifactor analysis of variance, multifactor ANOVA 多因素方差分析Multiple dosage 多剂量给药Multiple-dosage function 多剂量函数Multiple-dosage regimen 多剂量给药方案Multiple intravenous injection 多次静脉注射Myoglobin 肌血球素※<N>Naive average data, NAD 简单平均数据法Naive pool data, NPD 简单合并数据法Nanoparticles 纳米粒Nasal cavity 鼻腔Nasal mucosa 鼻粘膜National Institute of Health 美国国立卫生研究所Nephron 肾原Nephrotoxicity 肾毒性No hysteresis 无滞后Non-compartmental analysis, NCA 非隔室模型法Non-compartmental assistant Technology 非隔室辅助技术Nonionized form 非离子型Nonlinear mixed effects models, NONMEM 非线性混合效应模型Nonlinear pharmacokinetics 非线性药物动力学Non-linear relationship 非线性关系Nonparametric test 非参数检验※<O>Objective function, OF 目标函数Observed values 观测值One-compartment model 一室模型(单室模型)Onset 发生Open randomized two-way crossover design 开放随机两路交叉实验设计Open crossover randomized design 开放交叉随机设计Oral administration 口服给药Ordinary least squares, OLS 常规最小二乘法Organ 器官Organ clearance 器官清除率Original data 原始数据Osmosis 渗透压作用Outlier 偏离数据Outlier consideration 异常值的考虑Over-parameterized 过度参数化Oxidation 氧化Oxidation reactions 氧化反应※<P>Paracellular pathway 细胞旁路通道Parameters 参数Passive diffusion 被动扩散Pathways 途径Patient 病人Peak concentration 峰浓度Peak concentration of drug in plasma 血浆中药物峰浓度Poly-peptide 多肽Percent of absorption 吸收百分数Percent of fluctuation, PF 波动百分数Perfused liver 灌注肝脏Period 周期Peripheral compartments 外周室Peristalsis 蠕动Permeability of cell membrane 细胞膜的通透性P-glycoprotein, p-gp P-糖蛋白Phagocytosis 吞噬Pharmaceutical dosage form 药物剂型pharmaceutical equivalents 药剂等效性Pharmacokinetic models 药物动力学模型Pharmacokinetic physiological models 药物动力学的生理模型Pharmacological effects 药理效应Pharmacologic efficacy 药理效应Pharmacokinetics, PK 药物动力学Pharmacokinetic/pharmacodynamic link model 药物动力学-药效动力学统一模型Pharmacodynamics, PD 药效动力学Pharmacodynamic model 药效动力学模型Phase II metabolism 第II相代谢Phase I metabolism 第I相代谢pH-partition hypothesis pH分配假说Physiological function 生理功能Physiological compartment models 生理房室模型Physiological pharmacokinetic models 生理药物动力学模型Physiological pharmacokinetics 生理药物动力学模型Pigment 色素Physicochemical factors 理化因素Physicochemical property of drug 药物理化性质Physiological factors 生理因素Physiology 生理Physiological pharmacokinetic models 生理药物动力学模型Pinocytosis 吞噬Plasma drug concentration 血浆药物浓度Plasma drug concentration-time curve 血浆药物浓度-时间曲线Plasma drug-protein binding 血浆药物蛋白结合Plasma metabolite concentration 血浆代谢物浓度Plasma protein binding 血浆蛋白结合Plateau level 坪浓度Polymorphism 多态性Population average pharmacokinetic parameters 群体平均动力学参数Population model 群体模型Population parameters 群体参数Population pharmacokinetics 群体药物动力学Post-absorptive phase 吸收后相Post-distributive phase 分布后相Posterior probability 后发概率practical pharmacokinetic program 实用药代动力学计算程序Precision 精密度Preclinical 临床前的Prediction errors 预测偏差Prediction precision 预测精度Predicted values 拟合值Preliminary structural model 初始结构模型Primary active transport 原发性主动转运Principle of superposition 叠加原理Prior distribution 前置分布Prodrug 前体药物Proliferation assays 细胞增殖法Proportional 比例型Proportional errors 比例型误差Prosthehetic group 辅基Protein 蛋白质Pseudo-distribution equilibrium 伪分布平衡Pseudo steady state 伪稳态Pulmonary location 肺部Pulsatile drug delivery system 脉冲式释药系统※<Q、R>QQuality controlled samples 质控样品Quality control 质量控制Quick tissue 快分布组织RRadioimmuno assays, RIA 放射免疫法Random error model 随机误差模型Rapid intravenous injection 快速静脉注射Rate constants 速度常数Rate method 速度法Re-absorption 重吸收Receptor location 受体部位Recovery 回收率Rectal absorption 直肠吸收Rectal blood circulation 直肠部位的血液循环Rectal mucosa 直肠黏膜Reductase 还原酶Reduction 还原Reductive metabolism 还原代谢Reference individual 参比个体Reference product 参比制剂Relative bioavailability, Fr 相对生物利用度Release 释放Release medium 释放介质Release standard 释放度标准Renal 肾的Renal clearance, Clr 肾清除率Renal excretion 肾排泄Renal failure 肾衰Renal impairment 肾功能衰竭Renal tubular 肾小管Renal tubular re-absorption 肾小管重吸收Renal tubular secretion 肾小管分泌Repeatability 重现性Repeated one-point method 重复一点法Requirements 要求Research field 研究内容Reside 驻留Respiration 呼吸Respiration organ 呼吸器官Response 效应Residuals 残留误差Residual random effects 残留随机效应Reversal 恢复Rich Data 富集数据Ritschel one-point method Ritschel 一点法Rotating bottle method 转瓶法Rough surfaced endoplasmic reticulum 粗面内质网Routes of administration 给药途径※<S、T>SSafety and efficacy therapy 安全有效用药Saliva 唾液Scale up 外推Scale-Up/Post-Approval Changes, SUPAC 放大/审批后变化Second moment 二阶矩Secondary active transport 继发性主动转运Secretion 分泌Sensitivity 灵敏度Serum creatinine 血清肌酐Sigma curve 西格玛曲线Sigma-minus method 亏量法(总和减量法)Sigmoid curve S型曲线Sigmoid model Hill’s方程Simulated design 模拟设计Single-dose administration 单剂量(单次)给药Single dose response 单剂量效应Sink condition 漏槽条件Skin 皮肤Slow Tissue 慢分布组织Smooth surfaced endoplasmic reticulum 滑面内质网Soluble cell sap fraction 可溶性细胞液部分Solvent drag effect 溶媒牵引效应Stability 稳定性Steady-state volume of distribution 稳态分布容积Sparse data 稀疏数据Special dosage forms 特殊剂型Special populations 特殊人群Specialized mucosa 特性粘膜Species 种属Species differences 种属差异Specificity 特异性专属性Square sum of residual error 残差平方和Stagnant layer 不流动水层Standard curve 标准曲线Standard two stage, STS 标准两步法Statistical analysis 统计分析Statistical moments 统计矩Statistical moment theory 统计矩原理Steady state 稳态Steady state plasma drug concentration 稳态血药浓度Stealth liposomes, SL 隐形脂质体Steroid 类固醇Steroid-sulfatases 类固醇-硫酸酯酶Structure 结构Structure and function of GI epithelial cells 胃肠道上皮细胞的构造与功能Subcutaneous injections 皮下注射Subgroup 亚群体Subjects 受试者Sublingual administration 舌下给药Sublingual mucosa 舌下粘膜Subpopulation 亚群Substrate 底物Sulfate conjugation 硫酸盐结合Sulfation 硫酸结合Sum of squares 平方和Summation 相加Superposition method 叠加法Susceptible subject 易受影响的患者Sustained-release preparations 缓释制剂Sweating 出汗Synergism 协同作用Systemic clearance 全身清除率TTargeting 靶向化Taylor expansion 泰勒展开Tenous capsule 眼球囊Test product 试验制剂Therapy drug monitoring, TDM 治疗药物监测Therapeutic index 治疗指数Thermospray 热喷雾Three-compartment models 三室模型Though concentration 谷浓度Though concentration during steady state 稳态谷浓度Thromboxane 血栓素Tight junction 紧密结合Tissue 组织Tissue components 组织成分Tissue interstitial fluid 组织间隙Tolerance 耐受性Topping effect 尖峰效应Total clearance 总清除率Toxication and emergency treatment 中毒急救Transcellular pathway 经细胞转运通道Transdermal absorption 经皮肤吸收Transdermal drug delivery 经皮给药Transdermal penetration 经皮渗透Transport 转运Transport mechanism of drug 药物的转运机理Trapezoidal rule 梯形法Treatment 处理Trial Simulator 实验计划仿真器Trophoblastic epithelium 营养上皮层Two-compartment models 二室模型Two one sided tests 双单侧t检验Two period 双周期Two preparations 双制剂Two-way crossover bioequivalence studies 双周期交叉生物等效性研究Typical value 典型值※<U~Z>UUnwanted 非预期的Uniformity 均一性Unit impulse response 单位刺激反应Unit line 单位线Urinary drug concentration 尿药浓度Urinary excretion 尿排泄Urinary excretion rate 尿排泄速率VVagina 阴道Vaginal Mucosa 阴道黏膜Validation 校验Variance of mean residence time, VRT 平均驻留时间的方差Vein 静脉室Villi 绒毛Viscre 内脏Volumes of distribution 分布容积volunteers or patients studies 人体试验WWagner method Wagner法Wagner-Nelson method Wagner-Nelson法Waiver requirements 放弃(生物等效性研究)要求Washout period 洗净期Weibull distribution function Weibull分布函数Weighted Least Squares WLS加权最小二乘法Weighted residuals 加权残留误差XXenobiotic 外源物, 异生素ZZero Moment 零阶矩Zero-order absorption 零级吸收Zero-order kinetics 零级动力学Zero order rate 零级速度Zero-order release 零级释放。

Health and Safety Executive潜水信息表说明书

Health and Safety Executive潜水信息表说明书

Health and SafetyIntroductionThis diving information sheet (DVIS) is part of a series of information sheets providing guidance on diving at work. It identifies the correct standard to be used for assessing the quality of divers’ breathing gas taking into account the 2014 version of BS EN 12021. It details the requirements for breathing gas composition and also provides guidance on the frequency of tests. Unit symbols and measurement Throughout this DVIS extracts from EH40/2005 Workplace Exposure Limits1 and BS EN 12021:2014 Respiratory equipment – Compressed gases for breathing apparatus2 are shown as ml m-3,mg m-3 and ppm (parts per million by volume). LegislationThe Control of Substances Hazardous toHealth Regulations 2002 (as amended) (COSHH)3 and the associated Approved Codeof Practice (ACOP) and guidance4 apply. Standard for divers’ breathing gasesBS EN 12021:20142 supersedes the previous1998 version of the standard and is the appropriate standard for compressed breathing gases usedby divers. The 2014 version of the standard provides details of the composition of breathingair, as well as the following breathing gases:n oxygen compatible air;n nitrogen depleted air;n oxygen enriched air;n breathing oxygen;n oxygen and nitrogen gas mixtures;n oxygen and helium gas mixtures;n oxygen, helium and nitrogen gas mixtures. Standards for divers’ breathing airThe standards for breathing air in BS EN 12021:20142 are detailed in Table A:Table A Composition of breathing air Component Concentration atatmospheric pressure Oxygen In the range of (21 +/- 1) % Carbon dioxide Less than or equal to500 ml m-3 (500 ppmby volume)Carbon monoxide Less than or equal to5 ml m-3 (5 ppm by volume) Oil Less than or equal to0.5 mg m-3 (Droplets or mist) Odour/taste No significant odour or taste Liquid water None presentWater contentThere should not be any free liquid water content in the breathing gas. The breathing gas must havea dew point sufficiently low to prevent condensation and freezing. The dew point is the temperature where water vapour condenses into liquid water 3. The allowable water content of diver’s breathingair is shown below in Tables B and C:Diver’s breathing gas standard and the frequency of examination and testsHSE information sheet1 of 5 pagesTable B Water vapour content of high pressure breathing airNominal maximum supply pressure Maximum water content of air at atmospheric pressure40 to 200 bar Less than or equalto 50 mg m-3 Greater than 200 bar Less than or equalto 35 mg m-3Compressors used for charging high pressure cylinders greater than 200 bar Less than or equal to 25 mg m-3Water vapour content for breathingair supplied at pressure up to 40 barThe maximum water content of air supplied at 40 bar and below, ie low pressure air compressor supplies for surface supplied diving equipment and compression chambers is provided in Table C below:Table C Water vapour content for breathing air up to 40 barNominal maximum supply pressure (bar)Maximum water content of air at atmospheric pressure and 20 °C mg m-3529010160151102080256530554050Other methods of establishing the maximum permitted water content have been developed. The details are outside the scope of this DVIS, but can be obtained from HSE Research Report 427 Moisture levels in compressed breathing air6. Standards for divers’ breathinggas – oxygen and nitrogengas mixtures (nitrox)The standards for breathing mixtures of oxygen and nitrogen in BS EN 12021:20142 are detailed inTable D:Table D Composition of oxygen and nitrogen mixesComponent Concentration at1013mb and 20 °COxygen mixes containing<20% by volume≥20% by volume(Stated a +/- 0.5b)%(Stated a +/- 1.0b)%) Nitrogen RemainderWater ≤ 15 mg m -3Carbon Dioxide≤ 5 ml m -3 (ppm) Carbon Monoxide≤ 3ml m -3 (ppm)Oil≤ 0.1 mg – m-3Total volatile non-substituted hydrocarbons(vapour or gas) asmethane equivalent≤ 30 ml m -3Other non-toxic gases c< 1%a Percentage as stated by the supplierb Tolerance value is a percentage of the total gas mixturec These gases include argon and all other noble gasesTable D is applicable to oxygen and nitrogen mixtures provided by industrial gas suppliers.Nitrox mixtures may also be generated by diving contractors themselves using membrane systems, decanting/gas booster systems, or other methods to produce nitrogen depleted air and oxygen enriched air.Health and SafetyExecutive2 of 5 pagesStandards for divers’ breathing gas – oxygen and helium gas mixtures (heliox)The standards for breathing mixtures of oxygen and helium in BS EN 12021:20142 are detailed in Table E:Table E Composition of oxygen and helium mixesComponent Concentration at1013mb and 20 °C Oxygen mixes containing≤ 10% by volume10% to ≤ 20% by volume ≥20% by volume (Stated a +/- 0.25 b)% (Stated a +/- 0.5 b)% (Stated a +/- 1.0 b)%Helium RemainderWater ≤ 15 mg m-3Carbon Dioxide≤ 5 ml m-3 (ppm) Carbon Monoxide≤ 0.2 ml m-3 (ppm)Oil≤ 0.1 mg m-3Total volatile non-substituted hydrocarbons(vapour or gas) asmethane equivalent≤ 30 ml m-3 (ppm)Hydrogen≤ 10 ml m-3 (ppm) Other non-toxic gases c< 0.5%a Percentage as stated by the supplierb Tolerance value is a percentageof the total gas mixturec These gases include argon andall other noble gasesNitrogen, water and carbon dioxide content applicable to diver gas recovery (reclaim) system compressor samplesThe standards for breathing mixtures of oxygenand helium in Table E above are fully applicable to the heliox mixtures provided for saturation diving operations by industrial diving gas suppliers. It is recognised that heliox mixtures found within diver gas recovery (reclaim) systems may have higher levels of moisture, nitrogen and carbon dioxide content than the maximum levels specified inTable E. NitrogenIn common with most gases, the physiological effects of nitrogen are related to its partial pressure at the depth it is being inhaled. A maximum of 5% nitrogen content in reclaim gases for depths up to 350 m would be acceptable.Water contentThere is a risk that increased moisture levels may lead to increased corrosion rates inside pressure vessels and pressurised pipework. Where pressure vessels and pressurised pipework are likely to contain higher levels of moisture than the maximum levels specified in Table E (eg inside reclaim systems), it is important for diving contractors to have arrangements in place to ensure that suitable examination, testing and certification of all such plant and equipment is periodically undertaken at an appropriate frequency. The increased moisture content within reclaim system gas is unlikely to cause internal freezing of regulators and valves etc when gas expands through the system. This is because reclaim systems are not high pressure systems and, in addition, the Joule-Thompson effect means that heliox does not cool on expansion. Nevertheless, the provision of heated gas supplies should also be considered when diving is carriedout in cold waters. Divers breathing gas will require active heating for dives deeper than 150 meters. When operating using breathing gas suppliedfrom a gas recovery (reclaim) system themaximum water vapour content of diver’sbreathing gas is shown in Table F.Table F Water vapour content for reclaimsystem breathing gas up to 40 barNominalmaximum supplypressure (bar)Maximum water contentof reclaim system gasat atmospheric pressureand 20 °C mg m-3104101528020200251753014540110Note: Reclaim gas based on dewpoint of 0 °C3 of 5 pagesCarbon dioxideThe source for diver reclaim make-up gas should comply with the requirements of BS EN 12021:2014 for carbon dioxide levels. The circulating gas supply within the reclaim system should be operated to minimise the carbon dioxide levels. Carbon dioxide levels within the circulating gas of diver reclaim systems should normally be limited to a maximum partial pressure of 5 mbar at the depth of the diver (ie 5000 ml m-3 (ppm) when the diver is on the surface, corresponding to 0.5% SEV (surface equivalent value)). With the exceptions of nitrogen, water vapour and carbon dioxide the standards for breathing mixtures of oxygen and helium in Table E should be applied to saturation diving diver reclaim systems. Other contaminantsA risk assessment should be carried out to establish if any other contaminants should be tested for in addition to those specified in BS EN 12021:20142. Compressor lubricant safety data sheet and/or the compressor manufacturer’s operation and maintenance manuals should be checked to seeif there are any specific substances that shouldbe tested for. In addition, the location of the compressor inlet should be checked in order to ensure that contaminated gas is not drawn in. Ifyou do identify potential sources of contamination (such as ventilation exhausts) and cannot re-locate the compressor inlet, then you should determinethe likely contaminants. If there is any doubt, additional tests for the likely contamination andmore frequent tests may be necessary.For UK application, where the gas is to be used for breathing at ambient pressures greater than 10 bar and/or periods in excess of 8 hours, the calculations given in EH 75/2 Occupational exposure limits for hyperbaric conditions should be applied to take account of the increased pressure and/or duration. Frequency of testsA competent person (see Note 2) should carry out the breathing gas tests. The purpose of periodic testingis to make sure that the control measures you have put in place are delivering the gas quality required by BS EN 12021:20142 (as required by the appropriate tables above). The frequency of tests should be based on a risk assessment, but tests shouldtake place at least every three months where the source of the divers’ breathing gas is a compressor system (including a reclaim compressor system unless deemed ‘oil free’ by the original equipment manufacturer), and more often when the quality ofthe breathing gas cannot be assured to these levels.Additional methods of assuring gas quality Monitor filter life by measuring running hoursor the volume of cylinders filled. Both of these methods rely on the contamination not exceedingthe levels assumed by the manufacturer in settingthe recommended hours or throughput.A more reliable method of assurance is for continuous in-line gas quality monitoring.One technique is to continuously monitor the moisture content of the filter cartridge. Filter cartridges are usually designed so that the drying element becomes saturated before there is any deterioration of the other elements. Monitoring the moisture content of the gas at the filter outlet can indicate when the filter has reached the end of its life.Carbon monoxide (CO) can be produced within a compressor as a result of breakdown of the lubricating oil caused by pyrolysis (chemical decomposition by heat). Pyrolysis can occur when the system is hot,but not necessarily overheating and the resulting short term high levels of CO would not necessarily be identified during periodic sampling. To minimise this hazard a CO catalyst in the filter system and/or online monitoring for CO content should be considered.Do not modify any filtration systems or compressors without seeking advice from the compressor and/or filter manufacturer.Checking contents of breathing mixtures Experience shows that it is possible for a gas mixture to be supplied which does not correspondto thecylinder markings. All diving breathing mixtures should be checked on receipt and re-checked immediately prior to connecting them to a diving gas supply or breathing apparatus charging system. Notes1 Workplace Exposure Limits (WELs) are Occupational Exposure Limits (OELs) set under COSHH,3 in order to help protect the healthof workers.2 A ‘competent person’ is a person having a combination of training, knowledge and experience that will mean they can do the job required in asafe and efficient manner, using the test apparatus provided for the task. The duty holder will haveto decide who the ‘competent person’ will be.3 Where the apparatus is used and stored at a known temperature the pressure dew point shallbe at least 5°C below the likely lowest temperature.4 of5 pagesWhere the conditions of usage and storage ofany compressed air supply is not known the pressure dew point shall not exceed -11°C References1 EH40/2005 Workplace Exposure Limits: Containing the list of workplace exposurelimits for use with the Control of Substances Hazardous to Health Regulations 20022 BS EN 12021:2014 Respiratory equipment – Compressed gases for breathing apparatus3 The Control of Substances Hazardousto Health Regulations 20024 Control of substances hazardous to health (Sixth edition). The Control of Substances Hazardous to Health Regulations 2002 (as amended). Approved Code of Practice and guidance L5 (Sixth edition) HSE Books 2013 ISBN 978 0 7176 658225 EH 75/2 Occupational exposure limits for hyperbaric conditions : Hazard assessment document HSE Books 2000 ISBN 978 0 7176 1899 66 HSE Research Report 427 Moisturelevels in compressed breathing air7 Respiratory protective equipment at work – a practical guide HSG 53: (Fourth edition) HSEBooks 2013 ISBN 978 0 7176 6454 2Further readingCommercial diving projects inland/inshore. Divingat Work Regulations 1997. Approved Code of Practice and guidance L104 (Second edition)HSE Books 2014 ISBN 978 0 7176 6593 8/pubns/books/l104.htmCommercial diving projects offshore. Divingat Work Regulations 1997. Approved Code of Practice and guidance L103 (Second edition)HSE Books 2014 ISBN 978 0 7176 6592 1/pubns/books/l103.htm Recreational diving projects. Diving at Work Regulations 1997. Approved Code of Practiceand guidance L105 (Second edition)HSE Books 2014ISBN 978 0 7176 6594 5/pubns/books/l105.htmMedia diving projects. Diving at Work Regulations 1997. Approved Code of Practice and guidance L106 (Second edition) HSE Books 2014 ISBN 978 0 7176 6595 2 /pubns/books/l106.htm Scientific and archaeological diving projects. Diving at Work Regulations 1997. Approved Code of Practice and guidance L107 (Second edition) HSE Books 2014 ISBN 978 0 7176 6596 9/pubns/books/l107.htmThe Diving at Work Regulations 1997 SI 1997/2776 The Stationery Office 1997 ISBN 0 11 065170 7Are you involved in a diving project at work? A brief guide to complying with health and safety law. Leaflet INDG266(rev 2) /pubns/indg266.htm Further informationFor information about health and safety, or to report inconsistencies or inaccuracies in this guidance, visit /. You can view HSE guidance online and order priced publications from the website. HSE priced publications are also available from bookshops. This guidance is issued by the Health and Safety Executive. Following the guidance is not compulsory, unless specifically stated, and you are free to take other action. But if you do follow the guidance you will normally be doing enough to comply with the law. Health and safety inspectors seek to secure compliance with the law and may refer to this guidance.This leaflet is available at:/pubns/dvis9.pdf.© Crown copyright If you wish to reuse this information visit /copyright.htm for details. First published 01/18.5 of 5 pagesPublished by the Health and Safety Executive DVIS9(rev2) 01/18。

BECODISC P 系列高纯度细胞化胶原浓缩过滤芯说明书

BECODISC P 系列高纯度细胞化胶原浓缩过滤芯说明书

Technical Data Sheet Depth FiltrationBECODISC® P RangePremium Depth Filter Medium with High-Purity CelluloseBECODISC P stacked disc cartridges arecharacterized by unparalleled purity. The ion andendotoxin content is significantly lower than forconventional depth filter media.In Eaton’s innovative BECODISC P stacked disccartridge’s range, high-purity celluloses form aunique structure, which even for microbe removaldoes not require mineral components.The specific advantages of BECODISC P stacked disccartridges:-Minimum endotoxin contents. This ensures productsafety-Increased endotoxin retention-Without the addition of mineral components,therefore minimum ion content particularly ofcalcium, magnesium and aluminum ions-Very high chemical resistance and mechanicalstability-Rinsing volume reduced by up to 50%, resulting inreduced process costs- A Validation Guide is available upon requestIngredientsBECODISC P stacked disc cartridges are made only ofhigh-purity cellulose and wet strength agents.Areas of ApplicationBECODISC P stacked disc cartridges can be used for filtration of all liquid media. Application options range from coarse filtration to microbe removal.BECODISC P Stacked Disc Cartridges BECODISC P stacked disc cartridges are cationic. They are characterized by adsorption charge-related during filtration. Additionally, the depth filter medium has a very low content of soluble ions, especially of calcium, magnesium and aluminum. The chemical resistance and bursting strength is extremely high. BECODISC P stacked disc cartridges are suitable for applications involving mechanical separation of particles and adsorptive retention of negatively charged particles. Due to the minimum endotoxin contents and the increased endotoxin reduction the depth filter medium is ideal for pharmaceutical processes. Guide to Choosing the Right BECODISC P Stacked Disc CartridgeB171Microbial removal and increased endotoxin retention B271Microbial and endotoxin reductionB351Fine filtration, activated carbon removalB551Clarifying filtration, particle separationB581Coarse filtration, particle separationPhysical DataThis information is intended as a guideline for the selection of BECODISC stacked disc cartridges.The water throughput is a laboratory value characterizing the different BECOPAD ® P depth filter medium types. It is not the recommended flow rate. 2 2B171 BECOPADP 1700.2 – 0.4 0.15 (3.9) < 1 > 21.8 (150) 1.9 (77) < 0.025 B271 BECOPAD P 2700.5 – 0.7 0.15 (3.9) < 1 > 21.8 (150) 3.3 (135) < 0.025 B351 BECOPAD P 3500.7 – 1.0 0.15 (3.9) < 1 > 21.8 (150) 3.9 (160) < 0.025 B551 BECOPAD P 5502.0 –3.00.15 (3.9)< 1 > 21.8 (150) 14.0 (570) < 0.025 B581 BECOPAD P 5808.0 – 10.0 0.15 (3.9)< 1> 21.8 (150)87.6(3571)< 0.025*B = Polypropylene version (e.g. B171)** 100 kPa = 1 bar*** Endotoxin content analysis after rinsing with 0.61 gal/ft² (25 l/m²) of WFI (Water for Injection)Ordering Information1 Flat adapter/Double O-ring adapter |2 With cell spacer rail |3 Cannot be combined with double O-ring adapterExample: B17162SFPolypropylene stacked disc cartridge with BECOPAD P170 depth filter sheets, nominal retention range from 0.2 to 0.4 µm, 16 filter cells, 10.9 in (276 mm) high , 12", with silicone gaskets and flat adapter.BECODISC 12", Ø 11.6 in (295 mm) BECODISC 16", Ø 15.8 in (402 mm)Number of cells 16 14 91 9 5 16 14 91 9 5 Filter surface area [ft² (m²)]20.5 (1.9) 17.8 (1.65) 11.8 (1.1) 11.8 (1.1) 6.4 (0.59) 39.8 (3.7) 34.4 (3.2) 22.6 (2.1) 22.6 (2.1) 12.4 (1.15) Pre-coat volume [gal (l)]²- 0.9 (3.6) 2.1 (8.0)- -- 1.8 (7.0) 4.1 (15.4)- -Overall height flat adapter [in (mm)]10.9 (276) 10.9 (276) 10.9 (276) 7.7 (195) 4.4 (101) 10.9 (276) 10.9 (276) 10.9 (276) 7.7 (195) 4.4 (101) Overall height double O-ring adapter [in (mm)] 13.0 (329) 13.0 (329) 13.0 (329) 10.0 (248) -13.0 (329) 13.0 (329) 13.0 (329) 10.0 (248) -Cell spacer rail- - ✓ - -- - ✓ - -1 Special stacked disc cartridge configuration with cell spacer rails providing increased mechanical stability forholding filter cake | 2 Calculated values (BECO depth filter sheets with 0.16 in/4.0 mm thickness)171BECOPAD depth filter sheet 171 = P 170 271 = P 270 351 = P 350 551 = P 550 581 = P 580BDesignB = Polypropylene6Construction (overall height)16 = 16 filter cells(10.9/13.0 in) (276/329 mm) 4 = 14 filter cells(10.9/13.0 in) (276/329 mm) 7 = 9 filter cells 2(10.9/13.0 in) (276/329 mm) 9 = 9 filter cells(7.7/10.0 in) (195/248 mm) 5 = 5 filter cells 3(4.4 in) (101 mm)2Size2 = 12", ∅ 11.6 in(295 mm) 4 = 16", ∅ 15.8 in(402 mm)SGasket material E = EPDM F = FEP-coatedsilicone core S = Silicone V = FluoroelastomerFAdapterF = Flat adapter S = Double O-ringadapter Y = Flat adapter withgrounding deviseCompliance NoticeBECO depth filter sheets fulfill the requirements of Regulation (EC) 1935/2004 as well as the FDA Guideline 21 CFR §177.2260 test criteria. The polypropylene components comply with Regulation (EU) 10/2011. The polypropylene meets FDA requirements, 21 CFR § 177.1520. The sealing materials (silicone, EPDM) meet FDA requirements, 21 CFR § 177.2600. The depth filter sheet and the polypropylene components of the BECODISC P stacked disc cartridges meet the requirements of the USP Plastic Class VI – 70 °C test. For further details on individual components and materials see the declaration of conformity.Ion Concentration after Extraction with 40% EthanolCa < 50Mg < 25Fe < 5Al < 5* After rinsing with 0.61 gal/ft² (25 l/m²) of 40% EthanolRecommendations for Avoiding Damage BECODISC stacked disc cartridges can be used only in the specified flow direction. This applies to product filtering as well as sanitizing with hot water, and sterilizing with the stacked disc cartridges with saturated steam. In order to avoid damage to the filter cells, the system should be protected with a suitable non-return valve.Refer to the insert included with each BECODISC stacked disc cartridge carton for detailed application information.Depending on the filtered liquids, the operating temperature should not exceed 176 °F (80 °C). Please contact Eaton regarding filtration applications at higher temperatures.Intermediate PlatesIf more than two BECODISC stacked disc cartridges (12" or 16") with double O-ring adapters are stacked in the housing, install a central spindle for safety reasons. In the event, more than one 16" BECODISC stacked disc cartridge (flat adapter/double O-ring adapter) is used in the housing, Eaton recommends the installation of stainless steel intermediate plates between the BECODISC stacked disc cartridges. When silicone/FEP coated gaskets are used the stainless steel plates are mandatory. Sanitizing and Sterilizing (Optional)Sterilizing with Hot WaterThe hot water temperature should be 185°F (85 °C). A differential pressure of 21.8psi (150 kPa, 1.5 bar) must not be exceeded when sterilizing with hot water. Sterilization time: At least 30 minutes once a temperature of 185°F (85 °C) is reached at all filter openings. In the interest of energy conservation, the water may be circulated provided the specified temperatures are maintained.Sterilizing with SteamThe wetted BECODISC stacked disc cartridges can be sterilized with saturated steam up to a maximum temperature of 250 °F (121 °C) as follows:Steam quality: The steam must be free of foreignparticles and impurities. Temperature: Max. 250 °F (121 °C)(saturated steam)Duration: Approx. 20 minutes after steam exitsfrom all filter valvesRinsing: After sterilizing with 0.61 gal/ft²(25 l/m²) at 1.25 times the flow rateFilter Preparation and FiltrationUnless already completed after sterilization, rinse the stacked disc cartridges with 0.61 gal/ft² (25 l/m²) of water at 1.25 times the flow rate prior to the first filtration. Check the entire filter for leakage at maximum operating pressure.High-proof alcoholic solutions and products that cannot be rinsed with water should be circulated with the product. Discard the rinsing solution after rinsing. Differential PressureTerminate the filtration process once the maximum permitted differential p ressure of 43.5psi (300 kPa,3 bar) is reached. A higher differential pressure could damage the depth filter sheet material. For safety reasons, a differential pressure of 21.8psi (150 kPa, 1.5 bar) should not be exceeded in applications for separating microorganisms.SafetyWhen used and handled correctly, there are no known unfavorable effects associated with this product. Further safety information can be found in the relevant Material Safety Data Sheet, which can be downloaded from our website.DisposalDue to their composition, BECODISC stacked disc cartridges can be disposed of as harmless waste. Comply with relevant current regulations, depending on the filtered product.StorageBECODISC stacked disc cartridges must be stored in a dry, odor-free, and well ventilated place.Do not expose the BECODISC stacked disc cartridges to direct sunlight.BECODISC stacked disc cartridges are intended for immediate use and should be used within 36 months after production date.Quality Assurance According to DIN EN ISO 9001 The Quality Management System of Eaton Technologies GmbH has been certified according to DIN EN ISO 9001.This certification verifies that a fully functioning comprehensive Quality Assurance System covering product development, contract controls, choice of suppliers, receiving inspections, production, final inspection, inventory management, and shipment has been implemented.Extensive quality assurance measures incorporate adherence to technical function criteria and chemical purity and quality recognized as safe under the German legislation governing the production of foods and beverages.All information is given to the best of our knowledge. However, the validity of the information cannot be guaranteed for every application, working practice and operating condition. Misuse of the product will result in all warrantees being voided.Subject to change in the interest of technical progress.North America44 Apple StreetTinton Falls, NJ 07724Toll Free: 800 656-3344 (North America only)Tel: +1 732 212-4700Europe/Africa/Middle EastAuf der Heide 253947 Nettersheim, Germany Tel: +49 2486 809-0 Friedensstraße 4168804 Altlußheim, Germany Tel: +49 6205 2094-0An den Nahewiesen 2455450 Langenlonsheim, Germany Tel: +49 6704 204-0 ChinaNo. 3, Lane 280,Linhong RoadChangning District, 200335Shanghai, P.R. ChinaTel: +86 21 5200-0099Singapore100G Pasir Panjang Road #07-08Singapore 118523Tel: +65 6825-1668BrazilRua Clark, 2061 - Macuco13279-400 - Valinhos, BrazilTel: +55 11 3616-8400For more information, pleaseemail us at ********************or visit /filtration© 2018 Eaton. All rights reserved. All trademarks andregistered trademarks are the property of their respectiveowners. All information and recommendations appearing inthis brochure concerning the use of products describedherein are based on tests believed to be reliable. However,it is the user’s responsibility to determine the suitability forhis own use of such products. Since the actual use byothers is beyond our control, no guarantee, expressed orimplied, is made by Eaton as to the effects of such use orthe results to be obtained. Eaton assumes no liabilityarising out of the use by others of such products. Nor is theinformation herein to be construed as absolutely complete,since additional information may be necessary or desirablewhen particular or exceptional conditions or circumstancesexist or because of applicable laws or governmentregulations.EN1 A 2.8.210-2018。

  1. 1、下载文档前请自行甄别文档内容的完整性,平台不提供额外的编辑、内容补充、找答案等附加服务。
  2. 2、"仅部分预览"的文档,不可在线预览部分如存在完整性等问题,可反馈申请退款(可完整预览的文档不适用该条件!)。
  3. 3、如文档侵犯您的权益,请联系客服反馈,我们会尽快为您处理(人工客服工作时间:9:00-18:30)。

x=0 φ (0) = V
x=L f (L) = 0
d 2φ = −λ2 (c1 − c 2 ), λ2 = stuff × L2 2 dx dc F dφ J1 = −D1 1 + c dx RT 1 dx dc F dφ c2 J 2 = −D2 2 − dx RT dx
Na+-K+ ATPase
Na+-K+ ATPase
Outside the cell K+ Na+•C•P Step 2 ADP Step 1 Step 3 P Step 4 Na+•C K+ Inside the cell Na+ K+•C Na+ K+•C•P
ATP
Osmosis
P1 P2
The cell at steady state
3 Na+
We need to model • pumps • ionic currents • osmotic forces
2 K+ Cl-
Ca2+
Typical ionic concentrations
Squid Giant Axon Intracellular Na+ K+ ClExtracellular Na+ K+ Cl437 20 556 110 2.5 90 155 5 112 50 397 40 13 138 3 19 136 78 Frog Sartorius Muscle Human Red Blood Cell
Control of Cell Volume and Membrane Potential
Basic reference: Keener and Sneyd, Mathematical Physiology
Basic problem
• The cell is full of stuff. Proteins, ions, fats, etc. • Ordinarily, these would cause huge osmotic pressures, sucking water into the cell. • The cell membrane has no structural strength, and the cell would burst.
Active pumping
• Clearly, the action of the pumps is crucial for the maintenance of ionic concentration differences • Many different kinds of pumps. Some use ATP as an energy source to pump against a gradient, others use a gradient of one ion to pump another ion against its gradient. • A huge proportion of all the energy intake of a human is devoted to the operation of the ionic pumps.
Boundary conditions
c1 (0) = c i , c 2 (0) = c i , φ (0) = V,
c1 (L) = c e c 2 (L) = c e φ (L) = 0
The short-channel limit
If the channel is short, then L ~ 0 and so λ ~ 0.
( ) ( )
This is the Goldman-Hodgkin-Katz equation. Note: a short channel implies independence of ion movement through the channel.
The long-channel limit
[S]e=[S’]e Ve
RT [S]e Vi − Ve = ln F [S]i
(The Nernst potential)
Note: equilibrium only. Tells us nothing about the current. In addition, there is very little actual ion transfer from side to side. We'll discuss the multi-ion case later.
Basic solution
• Cells carefully regulate their intracellular ionic concentrations, to ensure that no osmotic pressures arise • As a consequence, the major ions Na+, K+, Cl- and Ca2+ have different concentrations in the extracellular and intracellular environments. • And thus a voltage difference arises across the cell membrane. • Essentially two different kinds of cells: excitable and nonexcitable. • All cells have a resting membrane potential, but only excitable cells modulate it actively.
Volume control: The Pump-Leak Model
water
water + Solvent (conc. c)
At equilibrium:
P1 + kcT = P2
Note: equilibrium only. No information about the flow.
The Nernst equation
[S]i=[S’]i Vi
Permeable to S, not S’
Only very little ion transfer
spherical cell - radius 25 µm surface area - 8 x 10-5 cm2 total capacitance - 8 x 10-5 µF (membrance capacitance is about 1 µF/cm2) If the potential difference is -70 mV, this gives a total excess charge on the cell membrane of about 5 x 10-12 C. Since Faraday's constant, F, is 9.649 x 104 C/mole, this charge is equivalent to about 5 x 10-15 moles. But, the cell volume is about 65 x 10-9 litres, which, with an internal K+ concentration of 100 mM, gives about 6.5 x 10-9 moles of K+. So, the excess charge corresponds to about 1 millionth of the background K+ concentration.
Electrodiffusion: deriving current models
cell membrane Inside [S1+] = [S2-] = ci S1 S2 Outside [S1+] = [S2-] = ce
Poisson equation and electrodiffusion
If the channel is long, then 1/L ~ 0 and so 1/λ ~ 0.
1 d 2φ Then 2 2 = c1 − c 2 , which implies that c1 ≈ c 2 through the membrane. λ dx dc c1 = c 2 ⇒ 2 1 = −J1 − J 2 dx ⇒ c1 = c i + (c e − c i )x
d 2φ dφ Then = 0, which implies that the electric field, , is constant through the membrane. 2 dx dx dφ dc1 =v ⇒ − vc1 = −J1 dx dx c i − c e e−v ⇒ J1 = v 1− e−v −VF D1F 2 c i − c e exp RT ⇒ I1 = V LRT 1− exp −VF RT
These are the two most common current models. Note how they both have the same reversal potential, as they must. (Crucial fact: In electrically excitable cells gNa (or PNa) are not constant, but are functions of voltage and time. More on this later.)
Electrical circuit model of cell membrane
相关文档
最新文档